Bottom line
PHSYX vs GGHCX: the short answer
PHSYX (Putnam Global Health Care Fund) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 57% by weight.
PHSYX is cheaper at 0.79% vs 1.07% — a difference of $28 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +2.6% for GGHCX (reporting dates differ).
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
PHSYX vs GGHCX side by side
| PHSYX | GGHCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.79% | 1.07% |
| Annual cost per $10k | $79 | $107 |
| 10-yr cost on $10k (prospectus) | $978 | $1,784 |
| Max front load | 0% | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +1.5% | +9.2% |
| 5-yr return (annualized) | +8.1% | +2.6% |
| 10-yr return (annualized) | +7.8% | +5.8% |
| Best quarter | — | +19.6% |
| Worst quarter | — | −16.5% |
| Net assets (fund) | $1.5B | $1.2B |
| Number of holdings | 115 | 82 |
| Portfolio turnover | 67% | 59% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of PHSYX's top 25 holdings also appear in GGHCX's top 25.
| Holding | PHSYX | GGHCX |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 10.59% |
| Johnson & Johnson | 8.46% | 6.76% |
| UnitedHealth Group, Inc. | 6.93% | 6.17% |
| AbbVie, Inc. | 6.05% | 4.03% |
| Merck & Co., Inc. | 4.88% | 4.59% |
| Thermo Fisher Scientific, Inc. | 4.50% | 1.55% |
| Edwards Lifesciences Corp. | 2.80% | 1.56% |
| CVS Health Corp. | 2.74% | 2.52% |
| Gilead Sciences, Inc. | 2.63% | 3.63% |
| Cardinal Health, Inc. | 2.12% | 2.10% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.01% |
Source: SEC Form N-PORT
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between PHSYX and GGHCX?
Which is cheaper, PHSYX or GGHCX?
Should I own both PHSYX and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.